Drug Trial Radar · NCT06991348
Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole
Last checked: Nov 20, 2026Latest source record: Jul 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
128
Planned (sponsor's estimate)
Start
Jul 30, 2024
Primary completion
Nov 30, 2025
Study completion Nov 30, 2025
Sponsor
- Lead sponsor
- Carnot LaboratoriesIndustry
- Sponsor type
- Industry
- First posted
- May 27, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this clinical trial is to compare which of the two drugs best resolves symptoms in patients diagnosed with erosive and non-erosive gastroesophageal reflux disease, adult males and females. The main question is What is the proportion of patients with resolution of the main symptoms of gastroesophageal reflux disease at four weeks of treatment with pantoprazole vs tegoprazan.
Conditions
- Gastroesophageal Reflux Disease
Interventions
TegoprazanDrug
Tegoprazan 50 mg daily for 28 days
PantoprazoleDrug
Pantoprazole 40 mg daily for 28 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects with resolution of the main symptoms of gastroesophageal reflux diseaseTime frame: From enrollment to the end of treatment at 4 weeks
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Gastrologen S.A. de C.V.
Mexico City, Mexico City, Mexico · Recruiting
Saluz Investigación, S.C.
Boca del Río, Veracruz, Mexico · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.